<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : News Articles for S.1695 Biologics Price Competition and Innovation Act of 2007</title>
  <link href="http://www.opencongress.org/bill/110-s1695/atom_news" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-s1695/news" rel="alternate"/>
  <updated>2007-06-28T00:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/news/44856</id>
  <entry>
    <title>Senate Committee Passes Follow-On Biologics Bill</title>
    <link href="http://fdanews.com/newsletter/article?issueId=10382&amp;amp;amp;articleId=95263" rel="alternate"/>
    <id>tag:opencongress.org,2007-06-28:/commentary/774507</id>
    <updated>2007-06-28T00:00:00Z</updated>
    <author>
      <name>FDA news (subscription),&amp;nbsp;VA</name>
    </author>
    <content type="html">
The Biologics Price Competition and Innovation Act, S. 1695, allows the FDA to use its scientific discretion in approving products that are biosimilar to ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://fdanews.com/newsletter/article?issueId=10382&amp;amp;articleId=95263&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Panel OKs Bill to Spur Generic Versions of Biotech Drugs</title>
    <link href="http://public.cq.com/docs/cqm/cqmidday110-000002541731.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-06-27:/commentary/770963</id>
    <updated>2007-06-27T00:00:00Z</updated>
    <author>
      <name>Congressional Quarterly,&amp;nbsp;DC</name>
    </author>
    <content type="html">
... amendments from both sides, preserving what they described as a delicate compromise on the legislation ( S 1695 ), which was approved by voice vote. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://public.cq.com/docs/cqm/cqmidday110-000002541731.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>
